A Transformative Shift in Patient Engagement

According to a 2025 ZS survey of 127 life sciences executives, 93% of life sciences companies anticipate increased investments for data, digital, and AI in 2025. Regulatory bodies like the FDA and EMA are also encouraging the responsible use of AI in clinical and patient-facing applications, further accelerating adoption.

GenAI is no longer a futuristic concept—it is actively reshaping how life sciences companies engage with patients. From personalized communication to predictive analytics, GenAI is enabling a shift from reactive to proactive care models.

Strategic Levers for Competitive Advantage

To remain competitive and patient-centric, life sciences organizations must harness GenAI across six key domains:

1. Personalized Patient Communication

A key advancement in Gen AI for patient engagement is the ability to deliver highly personalized communication. AI-driven systems can analyze individual patient data to generate tailored messages and recommendations aligned with a person’s health status, preferences, and behavioral patterns. Patients benefit from timely, personalized reminders for medication adherence, dietary guidance, and motivational prompts that support treatment compliance and overall well-being.

2. Virtual Health Assistants

Gen AI-powered virtual health assistants are transforming how patients interact with healthcare systems. These assistants, deployed through chatbots or voice-enabled devices, provide instant, human-like responses to health-related queries. They support patients by managing appointment scheduling, prescription refills, and basic medical guidance. By enabling self-service and continuous support, these tools significantly enhance patient engagement while reducing the administrative burden on healthcare providers.

3. Patient Education

Gen AI is also revolutionizing patient education by creating content tailored to an individual’s comprehension level and specific health conditions. This technology simplifies complex medical terminology, procedures, and treatment options, making them more accessible and easily understood. As a result, patients are better informed and more empowered to participate in their care decisions, fostering a more engaged and health-literate patient population.

4. Predictive Analytics for Treatment Optimization

Gen AI plays a pivotal role in predictive analytics by processing vast datasets to forecast patient outcomes and recommend optimal treatment pathways. These insights enable healthcare providers to intervene early, personalize care strategies, and reduce costs. By identifying trends in patient behavior and treatment responses, AI supports more precise and proactive healthcare delivery.

5. Remote Monitoring and Telehealth

Integrating Gen AI with remote monitoring and telehealth platforms is reshaping patient engagement, particularly for chronic disease management and post-treatment recovery. AI systems analyze data from wearable devices and remote sensors to generate real-time health reports and alerts. This continuous monitoring allows for timely interventions, reduces the need for in-person consultations, and ensures consistent care delivery across diverse patient populations.

6. Data Privacy and Security

As GenAI transforms patient engagement, prioritizing data privacy and security is fundamental to building trust and compliance. Advanced AI algorithms are being designed with robust encryption and privacy-preserving techniques to protect sensitive patient information. Approaches such as federated learning allow organizations to derive insights from distributed data sources without compromising confidentiality, thereby maintaining trust while enabling innovation.

A Structured Roadmap for Implementation

To operationalize these opportunities, life sciences companies should adopt a phased, agile approach:

Phase 1: Strategy and Readiness Assessment

  • Conduct a Gen AI maturity audit across patient engagement touchpoints.
  • Identify high-impact use cases aligned with business goals and compliance requirements.

Phase 2: Pilot and Validate

  • Launch controlled pilots in areas like virtual assistants or predictive analytics.
  • Measure impact using KPIs such as patient satisfaction, adherence rates, and cost savings.

Phase 3: Scale and Integrate

  • Integrate successful pilots into enterprise systems (e.g., CRM, EHR).
  • Establish cross-functional AI governance to ensure ethical and regulatory alignment.

Phase 4: Monitor and Optimize

  • Continuously monitor AI performance and patient feedback.
  • Use adaptive learning models to refine personalization and predictive accuracy.

GenAI Proof of Concept in Life Sciences

Agent Assist for Marketing

Life Sciences marketing faces key challenges such as generic outreach, poor customer segmentation, and delayed responses due to a lack of real-time data. Wipro has conceptualized a GenAI-powered Agent Assist solution to address these issues. The solution enables AI-driven personalization, dynamic segmentation, and next-best-action recommendations. The solution empowers marketing and sales teams with lead prioritization, call preparation, and personalized engagement strategies tailored for healthcare professionals and patients.

The solution integrates with CRM systems, leveraging historical data, sentiment analysis, and competitive insights to generate real-time, customized content. The benefits include improved sales agent productivity, relevant lead interactions, increased engagement, and improved conversion rates.

Agent Assist for Query Management

Customer service operations often face challenges such as inefficient manual case management and fragmented escalation processes. These lead to longer resolution times and increased agent workload due to the absence of guided workflows and system integration.

Wipro’s GenAI-powered Agent Assist solution offers real-time guidance, AI-driven workflows, and integrated escalation management through a unified dashboard. Key features include contextual response recommendations, call summarization, and automated case creation. By streamlining workflows and enabling dynamic, data-driven training and support, the solution enhances agent productivity, reduces query resolution time, and improves customer engagement.

The Way Forward

Generative AI is doing more than improving patient engagement—it is reshaping it at its core. For life sciences companies, the strategic deployment of GenAI offers a powerful opportunity to deliver more personalized, efficient, and scalable care. However, unlocking this potential demands more than technology alone. A clear roadmap, disciplined data governance, and a patient-first approach are essential for success.

To move from vision to value, life sciences leaders should begin by prioritizing use cases with the most significant impact on patient outcomes and return on investment. Building cross-functional teams that integrate clinical, technical, and regulatory expertise is essential to ensure both innovation and compliance. Equally important is investing in secure, scalable AI infrastructure that can support long-term growth and adaptability. Finally, engaging patients early in designing and deploying GenAI solutions will foster trust, improve adoption, and ensure that these technologies truly serve the needs of those they are intended to help.

About the Authors

Sanjay Martis
Senior Partner and Head of Life Sciences, North America, Wipro Consulting

Sanjay brings over 30 years of experience in commercial life sciences as a practitioner and consultant. Sanjay is a seasoned senior executive with extensive expertise across the international life sciences sector, including information technology, pharmaceuticals, biotechnology, and medical devices.

Somnath (Som) Mukherjee
Vertical Head of Life Sciences, Wipro Americas

Som has over 25 years of experience in the IT and BPO services sector, primarily serving the Life Sciences industry in various leadership roles. He currently leads Wipro’s Life Sciences business in the Americas, with end-to-end responsibility for the portfolio’s P&L. Som is committed to customer success, leveraging his expertise in solution development, client engagement, and service delivery.